Sökning: onr:"swepub:oai:DiVA.org:su-226713" >
Opioid agonist trea...
Opioid agonist treatment in transition : A cross-country comparison between Austria, Germany and Switzerland
-
Schwarz, Tanja (författare)
-
Anzenberger, Judith (författare)
-
Busch, Martin (författare)
-
visa fler...
-
Gmel, Gerhard (författare)
-
- Kraus, Ludwig, 1955- (författare)
- Stockholms universitet,Centrum för socialvetenskaplig alkohol- och drogforskning (SoRAD),IFT Institut für Therapieforschung, Germany; ELTE Eötvös Loránd University, Hungary; University Medical Centre Hamburg-Eppendorf, Germany
-
Krausz, Michael (författare)
-
Labhart, Florian (författare)
-
Meyer, Maximilian (författare)
-
Schaub, Michael P. (författare)
-
Westenberg, Jean N. (författare)
-
Uhl, Alfred (författare)
-
visa färre...
-
(creator_code:org_t)
- 2024
- 2024
- Engelska.
-
Ingår i: Drug And Alcohol Dependence. - 0376-8716 .- 1879-0046. ; 254
- Relaterad länk:
-
https://doi.org/10.1...
-
visa fler...
-
https://urn.kb.se/re...
-
https://doi.org/10.1...
-
visa färre...
Abstract
Ämnesord
Stäng
- Background and Aims: OAT is a well developed and successful treatment strategy for opioid dependent patients in Europe. It has significantly contributed to the fight against the HIV and HCV pandemics, leading to an increased life expectancy in this population. Building on the OAT experiences in Austria, Germany, and Switzerland and their models of care, the objective of this study is to analyse experiences and changes in patient structures to identify necessary adaptations for the system of care.Methods: We analysed national register-based data from patients receiving OAT during the period spanning from 2010 to 2020 in Austria, Germany (cases), and Switzerland. We examined and compared OAT policies and practice at national levels through a review of literature and publicly available policy documents.Results: Across these three countries, the life expectancy of OAT patients increased substantially. The mean age increased from 33.0 in 2010 to 39.1 in 2020 in Austria, from 35.6 years to 41.5 years in Germany (cases), and from 39.6 to 47.1 in Switzerland, respectively. In all three countries, the percentage of patients/cases aged 60 years and older increased more than tenfold between 2010 and 2020.Conclusions: Integrated support models, reliable care structures, internationally comparable high treatment coverage, flexible prescribing practices, and a wide range of available OAT medications are successful strategies. The experiences in these countries indicate that it is possible to address the complex and chronic nature of opioid dependence and its concurrent mental and physical health challenges, resulting in an increasing life expectancy of OAT patients.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Hälsovetenskap -- Beroendelära (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Health Sciences -- Substance Abuse (hsv//eng)
Nyckelord
- Life expectancy among PWUD
- OAT models
- future needs of ageing PWUD
- complex concurrent conditions
Publikations- och innehållstyp
- ref (ämneskategori)
- art (ämneskategori)
Hitta via bibliotek
Till lärosätets databas
- Av författaren/redakt...
-
Schwarz, Tanja
-
Anzenberger, Jud ...
-
Busch, Martin
-
Gmel, Gerhard
-
Kraus, Ludwig, 1 ...
-
Krausz, Michael
-
visa fler...
-
Labhart, Florian
-
Meyer, Maximilia ...
-
Schaub, Michael ...
-
Westenberg, Jean ...
-
Uhl, Alfred
-
visa färre...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Hälsovetenskap
-
och Beroendelära
- Artiklar i publikationen
-
Drug And Alcohol ...
- Av lärosätet
-
Stockholms universitet